Literature DB >> 34263368

ASO Visual Abstract: A Prospective, Phase I/II, Open-Label Pilot Trial to Assess the Safety of Hyperthermic Intraperitoneal Chemotherapy After Oncological Resection of Pancreatic Adenocarcinoma.

Can Yurttas1, Philipp Horvath1, Imma Fischer2, Christoph Meisner2, Silvio Nadalin1, Ingmar Königsrainer1,3, Alfred Königsrainer1,4,5, Stefan Beckert1,6, Markus W Löffler7,8,9,10,11.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34263368     DOI： 10.1245/s10434-021-10254-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  1 in total

1.  ASO Author Reflections: First Do No Harm-Revisiting Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Trials to Reduce the Risk of Peritoneal Metastasis.

Authors:  Can Yurttas; Alfred Königsrainer; Markus W Löffler
Journal:  Ann Surg Oncol       Date:  2021-06-11       Impact factor: 5.344
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.